August MIMS update

We look at some of the recent changes to the medicines landscape, with new products, new indications, contraindications and more New Products Avatrombopag (as maleate) (Doptelet) is an orally bioavailable, small molecule thrombopoietin receptor (TPO-R) agonist. It stimulates proliferation and differentiation of megakaryocytes from bone marrow progenitor cells, resulting in an increased production of platelets.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous World news wrapup: 10 August 2023
Next Coalition leave disallowance motion an orphan